How much funding has Type6 raised?

Type6 has raised $3.7M in total funding, most recently a seed round.

Who are Type6's investors?

Type6's investors include Reinforced Ventures.

Where is Type6 headquartered?

Type6 is headquartered in Novato, California, United States.

Type6

Transformative medicines against kinase-addicted diseases.

Novato, United States · Founded 2019 · $3.7M raised

SaaS

Headquarters: Novato, California
Employees: 1–10
Founded: 2019
Business Model: B2B

Total Funding: $3.7M
Last Round: $3.7M Seed
Rounds: 1

About

Founded in 2019, Type6 Therapeutics pioneers OFF-state kinase inhibition using computational biology, multivalent chemistry, and allostery-aware drug design. Its lead CDK2 program shows 100x greater selectivity than competing inhibitors and a dual mechanism of potent inhibition plus targeted degradation, targeting aggressive cancers with p53 or MYC alterations.

Summary

Type6 is a SaaS company based in Novato, United States, founded in 2019. It has raised $3.7M in total across 1 round. Investors include Reinforced Ventures.